CIT ID: 6173
Program date: Monday, December 17, 2007, 12:00:00 PM
Presented by: Robert Darnell, M.D., Ph. D., The Rockefeller University

Abstract:

Dr. Darnell will speak about how brain-specific splicing factors interacting with splicing silencer and enhancer elements lead to RNA isoforms in the brain that are different from the corresponding isoforms in other organs. One of these splicing factors, NOVA, has a predilection for regulating the splicing of RNAs that encode proteins acting at the neuronal synapse.

Indeed, in the absence of NOVA in knock-out mice, synaptic NOVA targets are changed in sequence though not in level, with the consequence that LTP of slow inhibitory postsynaptic currents is completely and specifically absent. So, don’t forget splicing when you think of gene expression! And by the way, because NOVA was discovered as a target of an auto-immune reaction in patients with a particular form of a paraneoplastic neurological syndrome, Dr. Darnell’s talk should also be interesting to immunologists and clinicians.

NIH Neuroscience Seminar Series

Audio Podcasts				Video Podcasts
	Description	Runtime			Description	Runtime
	Enhanced Audio Podcast	1:11:15			Enhanced Video Podcast	1:11:15

CIT ID: 6090
Program date: Friday, December 14, 2007, 10:00:00 AM
Presented by: Elizabeth Nabel, M.D. and Griffin Rodgers, M.D.

Abstract:

OPASI ROUNDS Lecture Series

The Office of Portfolio Analysis and Strategic Initiatives (OPASI) provides the National Institutes of Health (NIH) and its constituent Institutes and Centers (ICs) with the methods and information necessary to manage their large and complex scientific portfolios, identifies – in concert with multiple other inputs – important areas of emerging scientific opportunities or rising public health challenges, and assists in the acceleration of investments in these areas, focusing on those involving multiple ICs.

Audio Podcasts				Video Podcasts
	Description	Runtime			Description	Runtime
	Enhanced Audio Podcast	1:26:42			Enhanced Video Podcast	1:26:42

CIT ID: 6203
Program date: Wednesday, December 12, 2007, 3:00:00 PM
Presented by: Jack W. Szostak, Massachusetts General Hospital

Abstract:

The complexity of modern biological life has long made it difficult to understand how life could emerge spontaneously from the chemistry of the early earth. The key to resolving this mystery lies in the simplicity of the earliest living cells. Through our efforts to synthesize extremely simple artificial cells, we hope to discover plausible pathways for the transition from chemical evolution to Darwinian evolution. We view the two key components of a primitive cell as a self-replicating nucleic acid genome, and a self-replicating boundary structure. I will discuss recent experimental progress towards the synthesis of self-replicating nucleic acid and membrane vesicle systems, and the implications of these experiments for our understanding of the origin of life.

Dr. Szostak is an Investigator of the Howard Hughes Medical Institute, Professor of Genetics at Harvard Medical School, and the Alex Rich Distinguished Investigator in the Dept. of Molecular Biology and the Center for Computational and Integrative Biology at Massachusetts General Hospital. His current research interests are in the laboratory synthesis of self-replicating systems, the origin of life, and applied evolutionary chemistry. He and his colleagues have developed in vitro selection as a tool for the isolation of rare functional RNA, DNA and protein molecules from large pools of random sequences. His laboratory has used in vitro selection and directed evolution to isolate and characterize numerous nucleic acid sequences with specific ligand binding and catalytic properties. For this work, Dr. Szostak was awarded, along with Dr. Gerald Joyce, the 1994 National Academy of Sciences Award in Molecular Biology and the 1997 Sigrist Prize from the University of Bern. Dr. Szostak is a member of the National Academy of Sciences, and a Fellow of the New York Academy of Sciences and the American Academy of Arts and Sciences. In 2000, Dr. Szostak was awarded the Medal of the Genetics Society of America, and in 2006 Dr. Szostak shared the Albert Lasker Basic Medical Research Award with Elizabeth Blackburn and Carol Greider.

For more information, visit
http://www.hhmi.org/research/investigators/szostak.html

The NIH Director's Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.

Audio Podcasts				Video Podcasts
	Description	Runtime			Description	Runtime
	Enhanced Audio Podcast	1:05:55			Enhanced Video Podcast	1:05:55

CIT ID: 6327
Program date: Monday, December 10, 2007, 9:30:00 AM
Presented by: Adam Bosworth, Bern Shen and Bill Crounse

Abstract:

Using Behavioral Research and Innovative Technologies to Create new Evidence-Based Health Solutions

Audio Podcasts				Video Podcasts
	Description	Runtime			Description	Runtime
	Enhanced Audio Podcast	3:02:10			Enhanced Video Podcast	3:02:10

The NIH does not endorse or recommend any commercial products, processes, or services. The U.S. Government does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed. The NIH disclaims all warranties regarding these products, including, but not limited to, all warranties, express or implied of merchantability and fitness for any particular purpose. The NIH further disclaims all obligations and liabilities for damages arising from the use or attempted use of these products, including but not limited to direct, indirect, special, and consequential damages, attorneys' and experts' fees and court costs. Any use of these products will be at the risk of the user.